BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 15097961)

  • 1. Standard immunostains for melanoma in sentinel lymph node specimens: which ones are most useful?
    Karimipour DJ; Lowe L; Su L; Hamilton T; Sondak V; Johnson TM; Fullen D
    J Am Acad Dermatol; 2004 May; 50(5):759-64. PubMed ID: 15097961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraoperative evaluation of sentinel lymph nodes for metastatic melanoma by imprint cytology.
    Creager AJ; Shiver SA; Shen P; Geisinger KR; Levine EA
    Cancer; 2002 Jun; 94(11):3016-22. PubMed ID: 12115392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of HMB-45 and anti-Melan A staining of sentinel lymph nodes with isolated positive cells.
    Mahmood MN; Lee MW; Linden MD; Nathanson SD; Hornyak TJ; Zarbo RJ
    Mod Pathol; 2002 Dec; 15(12):1288-93. PubMed ID: 12481009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiosyncrasies of scalp melanoma.
    Rigual NR; Cheney RT; Iwenofu OH; Li Q; Loree TR; Popat SR; Merzianu M
    Laryngoscope; 2007 Aug; 117(8):1354-8. PubMed ID: 17592396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KBA.62: a useful marker for primary and metastatic melanomas.
    Pagès C; Rochaix P; al Saati T; Valmary-Degano S; Boulinguez S; Launay F; Carle P; Lauwers F; Payoux P; Le Guellec S; Brousset P; Lamant L
    Hum Pathol; 2008 Aug; 39(8):1136-42. PubMed ID: 18495211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel lymph nodes containing very small (<0.1 mm) deposits of metastatic melanoma cannot be safely regarded as tumor-negative.
    Murali R; DeSilva C; McCarthy SW; Thompson JF; Scolyer RA
    Ann Surg Oncol; 2012 Apr; 19(4):1089-99. PubMed ID: 22271204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraoperative touch imprint cytological analysis of sentinel lymph nodes for the presence of metastases in malignant melanoma.
    Tamiolakis D; Venizelos J; Jivanakis T; Antoniou C; Economou C; Tsiminikakis N; Georgiou G; Alexiadis G; Costopoulou A
    Minerva Med; 2008 Feb; 99(1):15-21. PubMed ID: 18299693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis.
    Spanknebel K; Coit DG; Bieligk SC; Gonen M; Rosai J; Klimstra DS
    Am J Surg Pathol; 2005 Mar; 29(3):305-17. PubMed ID: 15725798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphatic invasion detected by D2-40/S-100 dual immunohistochemistry does not predict sentinel lymph node status in melanoma.
    Petitt M; Allison A; Shimoni T; Uchida T; Raimer S; Kelly B
    J Am Acad Dermatol; 2009 Nov; 61(5):819-28. PubMed ID: 19836642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal detection of sentinel lymph node metastases by intraoperative radioactive threshold and molecular analysis in patients with melanoma.
    Manca G; Romanini A; Pellegrino D; Borsò E; Rondini M; Orlandini C; Zucchi V; Pasqualetti F; Mariani G
    J Nucl Med; 2008 Nov; 49(11):1769-75. PubMed ID: 18927334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S100, HMB-45, and Melan-A negative primary melanoma.
    Shinohara MM; Deubner H; Argenyi ZB
    Dermatol Online J; 2009 Sep; 15(9):7. PubMed ID: 19930994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of micrometastases in sentinel lymph nodes of cutaneous melanoma: higher diagnostic accuracy with Melan-A and MART-1 compared with S-100 protein and HMB-45.
    Shidham VB; Qi DY; Acker S; Kampalath B; Chang CC; George V; Komorowski R
    Am J Surg Pathol; 2001 Aug; 25(8):1039-46. PubMed ID: 11474288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic significance of isolated immunohistochemically positive cells in sentinel lymph nodes of melanoma patients.
    Murali R; Thompson JF; Shaw HM; Scolyer RA
    Am J Surg Pathol; 2008 Jul; 32(7):1106-7; author reply 1107-8. PubMed ID: 18521043
    [No Abstract]   [Full Text] [Related]  

  • 14. HMB-45 may be a more sensitive maker than S-100 or Melan-A for immunohistochemical diagnosis of primary oral and nasal mucosal melanomas.
    Yu CH; Chen HH; Liu CM; Jeng YM; Wang JT; Wang YP; Liu BY; Sun A; Chiang CP
    J Oral Pathol Med; 2005 Oct; 34(9):540-5. PubMed ID: 16138892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of isolated HMB45 or Melan A positive cells in Melanoma sentinel lymph nodes.
    Satzger I; Völker B; Meier A; Schenck F; Kapp A; Gutzmer R
    Am J Surg Pathol; 2007 Aug; 31(8):1175-80. PubMed ID: 17667539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel node identification by scintigraphic methods in cutaneous melanoma.
    Dias Moreira R; Altino de Almeida S; Maliska Guimarães CM; Resende JF; Gutfilen B; Barbosa da Fonseca LM
    J Exp Clin Cancer Res; 2005 Jun; 24(2):181-5. PubMed ID: 16110749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of molecular staging study of sentinel lymph nodes by reverse transcriptase-polymerase chain reaction for tyrosinase in melanoma patients.
    Mangas C; Hilari JM; Paradelo C; Rex J; Fernández-Figueras MT; Fraile M; Alastrue A; Ferrándiz C
    Ann Surg Oncol; 2006 Jul; 13(7):910-8. PubMed ID: 16788751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of Sox10 immunohistochemical staining for the detection of metastatic melanoma in sentinel lymph nodes.
    Blochin E; Nonaka D
    Histopathology; 2009 Nov; 55(5):626-8. PubMed ID: 19912373
    [No Abstract]   [Full Text] [Related]  

  • 19. Glycoconjugate profiling of primary melanoma and its sentinel node and distant metastases: implications for diagnosis and pathophysiology of metastases.
    Thies A; Berlin A; Brunner G; Schulze HJ; Moll I; Pfüller U; Wagener C; Schachner M; Altevogt P; Schumacher U
    Cancer Lett; 2007 Apr; 248(1):68-80. PubMed ID: 16822608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can Melan-A replace S-100 and HMB-45 in the evaluation of sentinel lymph nodes from patients with malignant melanoma?
    Kucher C; Zhang PJ; Acs G; Roberts S; Xu X
    Appl Immunohistochem Mol Morphol; 2006 Sep; 14(3):324-7. PubMed ID: 16932024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.